Product Information

CLORAZEPATE 7.5 MG TABLET is a generic product labeled by NorthStar Rx LLC, priced at $0.7301 per EA under NDC 72603011301. Its NADAC has been published 194 times since Mar 8, 2023.

FDA first approved this application on Apr 27, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CLORAZEPATE 7.5 MG TABLET

Clorazepate Dipotassium
$0.7301per EA
DEA Schedule CIV

Strength

7.5 mg/1

Manufacturer

NorthStar Rx LLC

NDC

72603011301

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

CLORAZEPATE DIPOTASSIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA075731

FDA Approved

4/27/2000

TE Code

AB

On Market Since

10/24/2022

Pharmacological Classes

Benzodiazepine
Benzodiazepines

Price Statistics

The NADAC for CLORAZEPATE 7.5 MG TABLET has been published 194 times since Mar 8, 2023, and over the history we have for it it has declined 51.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.7301 per EA
All-time high$1.5873 (Apr 12, 2023)
All-time low$0.7117 (Apr 22, 2026)
52-week high$0.9390
52-week low$0.7117
Median price$1.0432
Average price$1.0471
Largest weekly change+37.5% (Feb 21, 2024)
Weeks tracked194
Tracking sinceMar 8, 2023

Price History

1W

-6.1%

1M

-12.9%

3M

-16.3%

6M

-2.2%

1Y

-22.2%

3Y

-35.8%

5Y

N/A

All

-51.8%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CLORAZEPATE 7.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CLORAZEPATE 7.5 MG TABLET, manufactured by NorthStar Rx LLC, is $0.7301 per EA (NDC 72603011301), effective Nov 18, 2026.

How has the price of CLORAZEPATE 7.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for CLORAZEPATE 7.5 MG TABLET has declined 51.8%. It has been tracked across 194 weekly CMS publications since Mar 8, 2023.

What are the highest and lowest recorded NADAC prices for CLORAZEPATE 7.5 MG TABLET?

Since Mar 8, 2023, the NADAC for CLORAZEPATE 7.5 MG TABLET has ranged from a low of $0.7117 (Apr 22, 2026) to a high of $1.5873 (Apr 12, 2023), with a median of $1.0432 per EA.

Are there cheaper alternatives to CLORAZEPATE 7.5 MG TABLET?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLORAZEPATE 7.5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures CLORAZEPATE 7.5 MG TABLET?

CLORAZEPATE 7.5 MG TABLET (NDC 72603011301) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.